<DOC>
	<DOCNO>NCT01250457</DOCNO>
	<brief_summary>The purpose research find use topical timolol 0.5 % solution apply twice daily help shrink rosacea lesion around eye .</brief_summary>
	<brief_title>Topical Timolol Treatment Benign Vascular Periocular Lesions</brief_title>
	<detailed_description>Benign vascular tumor eyelid common cause ocular morbidity . Capillary hemangiomas child cause refractive occlusive amblyopia . In adult , Rosacea-associated eyelid telangiectasis sclerosis result keratitis corneal neovascularization . Corticosteroid therapy benign vascular lesion risk sight-threatening complication include central retinal artery occlusion significant systemic morbidity . Alternatively , oral intravenous beta-blockers report induce regression benign vascular lesion . One recent report document efficacy topical timolol treat large capillary hemangioma eyelid child . Topical application reduces systemic side effect beta-blockers include bradycardia , hypotension , heart block , bronchospasm . This one-year prospective case-control series investigate whether topical Timolol 0.5 % solution apply twice daily cause significant regression benign vascular periocular lesion .</detailed_description>
	<mesh_term>Timolol</mesh_term>
	<criteria>Presence benign vascular periocular lesion Allergy timolol betablocker class drug Lesion characteristic concern atypia malignancy include madarosis , ulceration , recurrence previous surgery . Intraocular Pressure le 10 mm Hg</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>